AssetMark’s iShares Neuroscience and Healthcare ETF IBRN Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRN
AssetMark's IBRN Position: Q3 2026 in Review
AssetMark sold out of iShares Neuroscience and Healthcare ETF (IBRN) in Q3 2026, closing a stake of 100 shares — an estimated $3.88K sold.
AssetMark first reported a position in IBRN in Q2 2026 and held it in 1 quarter. The position peaked at $3.88K in Q2 2026. 2 funds tracked by Wall St. Rank hold IBRN as of Q3 2026.
- AssetMark reported no remaining iShares Neuroscience and Healthcare ETF position as of Q3 2026 after selling out during the quarter.
- AssetMark sold 100 iShares Neuroscience and Healthcare ETF shares in Q3 2026, an estimated $3.88K.
- AssetMark first reported a position in iShares Neuroscience and Healthcare ETF in Q2 2026 and held it in 1 quarter.
- AssetMark's iShares Neuroscience and Healthcare ETF position peaked at $3.88K in Q2 2026.
- 2 funds tracked by Wall St. Rank held iShares Neuroscience and Healthcare ETF as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.